We assessed the impact of ACB1801 on the expression of antigen presentation genes (TAP1, TAP2, Tapasin, b2m, Lmp2, Lmp10, PA28α and PA26β) in murine B16-F10 melanoma. This evidence concerns the gene B2M and melanoma.